Amendment: Executive VP, North America Durbin Sean sold $1,902,815 worth of Ordinary Shares (4,169 units at $456.42), exercised 12,170 units of Ordinary Shares at a strike of $154.00 and covered exercise/tax liability with 8,001 units of Ordinary Shares, increasing direct ownership by 0.00% to 8,151 units (SEC Form 4)
$LIN
Major Chemicals
Industrials
| FORM 4 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||
| Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). | |||||||||||||||||
| Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10. | |||||||||||||||||
1. Name and Address of Reporting Person*
(Street)
|
2. Issuer Name and Ticker or Trading Symbol
LINDE PLC [ LIN ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
||||||||||||||||||||||||
|
3. Date of Earliest Transaction
(Month/Day/Year) 08/16/2024 | ||||||||||||||||||||||||||
|
4. If Amendment, Date of Original Filed
(Month/Day/Year) 08/16/2024 |
6. Individual or Joint/Group Filing (Check Applicable Line)
|
| Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 1. Title of Security (Instr. 3) | 2. Transaction Date (Month/Day/Year) | 2A. Deemed Execution Date, if any (Month/Day/Year) | 3. Transaction Code (Instr. 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) | 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
| Code | V | Amount | (A) or (D) | Price | ||||||
| Ordinary Shares | 08/16/2024 | M | 12,170 | A | $154 | 20,320.567 | D | |||
| Ordinary Shares | 08/16/2024 | F | 8,001(1) | D | $456.48 | 12,319.567 | D | |||
| Ordinary Shares | 08/16/2024 | S | 4,169 | D | $456.42 | 8,150.567 | D | |||
|
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
| Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
| Restricted Stock Units | (2) | (2) | (2) | Ordinary Shares | 1,470 | 1,470 | D | ||||||||
| Restricted Stock Units | (3) | (3) | (3) | Ordinary Shares | 1,595 | 1,595 | D | ||||||||
| Restricted Stock Units | (4) | (4) | (4) | Ordinary Shares | 1,430 | 1,430 | D | ||||||||
| Stock Options (right to buy) | $270.99 | 03/07/2023(5) | 03/07/2032(5) | Ordinary Shares | 12,395 | 12,395 | D | ||||||||
| Stock Options (right to buy) | $465.29 | 03/07/2025(6) | 03/07/2034 | Ordinary Shares | 9,610(7) | 9,610 | D | ||||||||
| Stock Options (right to buy) | $354.14 | 03/07/2024(8) | 03/07/2033 | Ordinary Shares | 10,540 | 10,540 | D | ||||||||
| Stock Options (right to buy) | $253.68 | 03/08/2022(9) | 03/08/2031 | Ordinary Shares | 19,070 | 19,070 | D | ||||||||
| Stock Options (right to buy) | $173.13 | 03/09/2021(10) | 03/09/2030 | Ordinary Shares | 7,045 | 7,045 | D | ||||||||
| Stock Options (right to buy) | $176.63 | 03/20/2020(11) | 03/20/2029 | Ordinary Shares | 7,795 | 7,795 | D | ||||||||
| Stock Options (right to buy) | $154 | 08/16/2024 | M | 12,170 | 02/27/2019(12) | 02/27/2028(12) | Ordinary Shares | 12,170 | $0 | 0 | D | ||||
| Deferred Stock Units | (13) | (14) | (14) | Ordinary Shares | 290.184 | 290.184 | D | ||||||||
| Explanation of Responses: |
| 1. Shares of common stock withheld from the payout to cover tax withholdings. |
| 2. Restricted Stock Units that will vest in full and payout on or about March 7, 2027 in Linde plc Ordinary Shares on a one-for-one basis. |
| 3. Restricted Stock Units that will vest in full and payout on or about March 7, 2026 in Linde plc Ordinary Shares on a one-for-one basis. |
| 4. Restricted Stock Units that will vest in full and payout on or about March 7, 2025 in Linde plc Ordinary Shares on a one-for-one basis |
| 5. This option vests over three years in three consecutive equal annual installments beginning on March 7, 2023. |
| 6. This option vests over three years in three consecutive equal annual installments beginning on March 7, 2025. |
| 7. The sole purpose of this Form 4 amendment is to correct the number of stock options granted on March 7, 2024, originally reported as "9,510" on Form 4 filed March 11, 2024 and to delete the reference to stock options in the amount of 5,945 granted February 28, 2017, which were exercised in full on March 3, 2023. All other information previously reported remains the same. |
| 8. This option vests over three years in three consecutive equal annual installments beginning on March 7, 2024. |
| 9. This option vests over three years in three consecutive equal annual installments beginning on March 8, 2022. |
| 10. This option vests over three years in three consecutive equal annual installments beginning on March 9, 2021. |
| 11. This option vests over three years in three consecutive equal annual installments beginning on March 20, 2020. |
| 12. This option vests over three years in three consecutive equal annual installments beginning on February 27, 2019. |
| 13. Conversion to Linde plc Ordinary Shares is on a one-to-one basis. |
| 14. Deferred stock units acquired under the Linde Compensation Deferral Plan as amended ("Plan"). The deferred stock units will payout in Linde plc Ordinary Shares on a one-for-one basis in accordance with the Plan. |
| Remarks: |
| Anthony M. Pepper as attorney-in-fact | 08/23/2024 | |
| ** Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
| * If the form is filed by more than one reporting person, see Instruction 4 (b)(v). | ||
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||